Label & Dose IVS: Financial statements 2020
CVR: 38204874
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Label & Dose IVS (CVR 38204874) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -5,625 and a net result of DKK -3,103 compared with DKK -41,160 the year before. Equity in the 2020 report amounted to DKK -43,450.
- Gross Profit
- DKK -5,625
- Profit/Loss
- DKK -3,103
- Equity
- DKK -43,450
- Total Assets
- DKK 2,051
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -6 t. | -3 t. | -43 t. | 0 |
| 2019 | - | -47 t. | -41 t. | -40 t. | 0 |
| 2018 | - | 19 t. | 17 t. | 813 | - |
Official annual report
How creditworthy is Label & Dose IVS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Label & Dose IVS has published its annual report for 2019. Gross profit came to DKK -47,081, and the net result was DKK -41,160.
About Label & Dose IVS
Label & Dose IVS was a Danish company of the type Iværksætterselskab based in København Ø, founded in 2016. The company has been dissolved on 29 October 2021. The company was registered under the industry Konsulentbistand vedrørende informationsteknologi. According to the 2020 annual report, the company had an average of 0 employees. In 2020, the company reported a gross profit of DKK -5,625 and a net result of DKK -3,103 compared with DKK -41,160 the year before. Equity in the 2020 report amounted to DKK -43,450.